Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Smadja

Showing results (191-200 of 225) with videos related to

Pageof 23
Sort By:
Thrombosis and Haemostasis|July 21, 2020
Autoregulation of Pulsatile Bioprosthetic Total Artificial Heart is Involved in Endothelial Homeostasis PreservationDavid M Smadja, Richard Chocron, Elisa Rossi, et al.
Annals of Intensive Care|July 17, 2021
Platelet activation in critically ill COVID-19 patientsNader Yatim, Jeremy Boussier, Richard Chocron, et al.
Journal of Thrombosis and Haemostasis : JTH|October 10, 2025
Prevention of hemorrhage after implantation of mechanical circulatory support with a purified von Willebrand factor concentrate: results of the early terminated randomized controlled trialAntoine Rauch, Guillaume Lebreton, Mouhamed D Moussa, et al.
Circulation|February 24, 2025
Aortic Valve Calcification Is Induced by the Loss of ALDH1A1 and Can Be Prevented by Agonists of Retinoic Acid Receptor Alpha: Preclinical Evidence for Drug RepositioningMickael Rosa, Annabelle Dupont, David M Smadja, et al.
Archives of Cardiovascular Diseases|March 1, 2023
Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammationAurélien Philippe, Richard Chocron, Guillaume Bonnet, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 10, 2022
Bioprosthetic Total Artificial Heart in Autoregulated Mode Is Biologically Hemocompatible: Insights for Multimers of von Willebrand FactorBastien Poitier, Richard Chocron, Christophe Peronino, et al.
Blood|October 16, 2016
PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics studyMaria Bruzelius, Maria Jesus Iglesias, Mun-Gwan Hong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve DiseaseNicolas Gendron, Mickael Rosa, Adeline Blandinieres, et al.
Angiogenesis|May 28, 2020
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patientsDavid M Smadja, Coralie L Guerin, Richard Chocron, et al.
European Heart Journal|December 16, 2017
The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysinMattia Arrigo, Nicolas Vodovar, Hélène Nougué, et al.
Pageof 23

Showing results (191-200 of 225) with videos related to

Sort By:
Pageof 23
Thrombosis and Haemostasis|July 21, 2020
Autoregulation of Pulsatile Bioprosthetic Total Artificial Heart is Involved in Endothelial Homeostasis PreservationDavid M Smadja, Richard Chocron, Elisa Rossi, et al.
Annals of Intensive Care|July 17, 2021
Platelet activation in critically ill COVID-19 patientsNader Yatim, Jeremy Boussier, Richard Chocron, et al.
Journal of Thrombosis and Haemostasis : JTH|October 10, 2025
Prevention of hemorrhage after implantation of mechanical circulatory support with a purified von Willebrand factor concentrate: results of the early terminated randomized controlled trialAntoine Rauch, Guillaume Lebreton, Mouhamed D Moussa, et al.
Circulation|February 24, 2025
Aortic Valve Calcification Is Induced by the Loss of ALDH1A1 and Can Be Prevented by Agonists of Retinoic Acid Receptor Alpha: Preclinical Evidence for Drug RepositioningMickael Rosa, Annabelle Dupont, David M Smadja, et al.
Archives of Cardiovascular Diseases|March 1, 2023
Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammationAurélien Philippe, Richard Chocron, Guillaume Bonnet, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 10, 2022
Bioprosthetic Total Artificial Heart in Autoregulated Mode Is Biologically Hemocompatible: Insights for Multimers of von Willebrand FactorBastien Poitier, Richard Chocron, Christophe Peronino, et al.
Blood|October 16, 2016
PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics studyMaria Bruzelius, Maria Jesus Iglesias, Mun-Gwan Hong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve DiseaseNicolas Gendron, Mickael Rosa, Adeline Blandinieres, et al.
Angiogenesis|May 28, 2020
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patientsDavid M Smadja, Coralie L Guerin, Richard Chocron, et al.
European Heart Journal|December 16, 2017
The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysinMattia Arrigo, Nicolas Vodovar, Hélène Nougué, et al.
Pageof 23